LRG Science Team

/LRG Science Team

About LRG Science Team

This author has not yet filled in any details.
So far LRG Science Team has created 45 blog entries.

Potential Treatment for Imatinib-Resistant GIST Explored

Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially [...]

By |2019-01-15T14:45:23-04:00June 16th, 2015|Drug Treatment, News, Research|

Blueprint Medicines Presents Preclinical Data on BLU-285

Blueprint Medicines presented new preclinical data on its drug candidate, BLU-285, and its potential value in  treatment-resistant GIST and on novel cancer drug targets at the AACR (American Association for Cancer Research) Annual Meeting [...]

By |2019-04-08T10:13:47-04:00April 24th, 2015|D842V, News, Research|

Study Indicates Use Of Adjuvant Imatinib Therapy For GIST Increasing

A recent study published in the American Journal of Clinical Oncology found that the use of adjuvant systemic therapy with imatinib for GIST has increased significantly over time, and that patients treated with the therapy [...]

By |2018-09-11T09:21:47-04:00April 7th, 2015|Drug Treatment, Gleevec, News, Survival Strategies|

Breaking Research Barriers – Our Unique Team Searches for a Cure

Breaking Research Barriers! The Life Raft Group Research Team is unique. As we know, the purpose of research is to inform, educate and allow us to live better lives.

By |2018-08-01T14:32:17-04:00June 4th, 2013|Fundraising, News, Research, Video|

Recent Posts

Upcoming Events

  1. Kathy Sarmiento Medicare 101 Webcast

    LRG Webcast Series: Medicare 101

    September 9 @ 12:00 PM - 1:00 PM
  2. GDOL Ottawa logo

    GIST Day of Learning – Ottawa

    September 28 @ 9:00 AM - 4:30 PM